Why Adjust for Baseline Blood Pressure?
In a randomized blood-pressure trial, participants are assigned to a treatment or a control group, and blood pressure is recorded before and after assignment. Randomization supports a fair comparison: before treatment, the groups should be comparable on average. Yet their observed baseline pressures can still differ by chance. Because baseline pressure is often related to follow-up pressure, accounting for it can make the treatment comparison more precise and can help explain the observed follow-up values.
A baseline-adjusted analysis compares the groups’ follow-up systolic blood pressure at the same baseline pressure, using a regression model. The result is not a comparison of raw group averages. It is a model-based adjusted difference, expressed in the outcome’s units. The model and its assumptions must be stated before interpreting that difference.
The Model and Its Assumptions
The model includes one baseline-pressure slope for both randomized groups. Thus, it assumes that the adjusted treatment difference is the same across the range of baseline pressures represented in the analysis. The coefficient \(\beta_1\) compares treatment with control while holding baseline pressure fixed; its units are mmHg. A negative estimate means lower model-estimated follow-up pressure in the treatment group at the same baseline pressure.
For ordinary least-squares estimates and the usual \(t\)-based confidence interval and test, the working assumptions are that the mean follow-up pressure is adequately described by a linear function of treatment assignment and baseline pressure; the errors have mean zero at each combination of these predictors; the errors are independent across participants; and their variance is constant. Normal errors are additionally assumed for exact small-sample \(t\)-inference. A sound analysis also requires an appropriate sample and no data errors or influential observations that make the fitted model misleading. These conditions are assessed using study design knowledge and diagnostics; no plot can establish them with certainty.
Baseline pressure should be measured before treatment assignment or before treatment can affect it. Adjusting for a post-assignment measure would be a different analysis and could introduce bias. A trial should also define the analysis sample and how missing outcomes are handled. The fitted model estimates the adjusted comparison for the participants included in that analysis, so exclusions or missing measurements affect the scope of the result.
Worked Example: Interpreting the Adjusted Difference
Suppose a hypothetical randomized trial assigns 80 adults to a new blood-pressure treatment or control. Baseline and follow-up systolic pressure are recorded in mmHg. All 80 participants have both measurements. The fitted model is
The estimate for treatment assignment is \(\hat{\beta}_1=-5.8\) mmHg. The model therefore estimates that, at the same baseline pressure, the treatment group has an average follow-up systolic pressure 5.8 mmHg lower than the control group. This is an adjusted group difference, not a claim that every treated participant’s pressure falls by 5.8 mmHg.
For example, at a baseline pressure of 150 mmHg, the fitted control value is \(18.4+0.91(150)=18.4+136.5=154.9\) mmHg. For treatment, it is \(18.4-5.8+0.91(150)=149.1\) mmHg. Their difference is \(149.1-154.9=-5.8\) mmHg. The two predictions have the same baseline value, so the baseline term cancels in the comparison.
The trial is randomized, the baseline measure precedes treatment, and the analysis includes all 80 hypothetical participants, so the comparison has a design-based rationale. The linear relationship and common slope are modeling assumptions that still need to be checked against the data. The coefficient alone does not establish that the model fits well or that the treatment effect is clinically important.
Why the Treatment Coefficient Is an Adjusted Difference
The interpretation follows directly from the model’s fitted mean. For a control participant, \(T_i=0\), so the model mean at baseline value \(X_i\) is \(\beta_0+\beta_2X_i\). For a treatment participant at that same baseline value, the model mean is \(\beta_0+\beta_1+\beta_2X_i\). Subtracting control from treatment gives
This cancellation is why \(\beta_1\) is the adjusted treatment difference, and why the stated model implies a common difference at every baseline value. It also makes clear that the result depends on the model’s form: if the model’s assumptions are inadequate, the coefficient may not summarize the comparison well.
In a randomized trial, assignment is the treatment indicator used in the analysis, whether or not every participant follows the assigned regimen. The interpretation must match the actual analysis and its handling of adherence and missing outcomes. Baseline adjustment is commonly used to improve precision, but it does not turn an inadequate model into an adequate one, nor does it remove the need to describe the trial design.
Quantifying Uncertainty
The estimated coefficient varies from sample to sample. Its standard error \(SE(\hat{\beta}_1)\) describes the estimated sampling variability of the treatment estimate under the model. A confidence interval combines the estimate and its standard error to show a range of values compatible with the data and modeling assumptions. For the usual linear regression inference, the interval uses a \(t\) critical value with residual degrees of freedom \(df=n-3\), because this model estimates three coefficients: an intercept, a treatment coefficient, and a baseline coefficient.
To test whether the adjusted difference is zero, the usual two-sided hypotheses are \(H_0:\beta_1=0\) and \(H_a:\beta_1\ne 0\). The test statistic is \(t=\hat{\beta}_1/SE(\hat{\beta}_1)\), compared with a \(t\) distribution having \(df=n-3\). The p-value is the probability, assuming \(H_0\) and the model conditions, of obtaining a test statistic at least as extreme in either direction as the observed one. It is not the probability that the null hypothesis is true.
Worked Example: Confidence Interval and Test
Continue with the hypothetical trial of 80 participants. Suppose the fitted treatment coefficient is \(-5.8\) mmHg and its standard error is \(2.1\) mmHg. For this model, \(df=80-3=77\). A two-sided 95% confidence interval uses \(t^*_{77}\approx1.991\).
The interval is
Thus, the 95% confidence interval is approximately \((-9.98,-1.62)\) mmHg. Under the model and its assumptions, this procedure gives intervals that cover the true adjusted difference in 95% of repeated samples. In this trial’s context, the interval is compatible with a treatment-group follow-up pressure about 1.62 to 9.98 mmHg lower than control at the same baseline pressure.
For the test of \(H_0:\beta_1=0\), the statistic is
With 77 degrees of freedom, the two-sided p-value is about 0.0072. If the prespecified significance level is \(\alpha=0.05\), this result is statistically significant because \(0.0072<0.05\). It is evidence against a zero adjusted difference under the model; it is not the probability that treatment has no effect. The confidence interval and test agree: the interval excludes zero. Whether a difference of this size is clinically worthwhile requires clinical context, not just a p-value.
Checking Residual Patterns
A residual is the observed follow-up pressure minus the fitted follow-up pressure, \(e_i=Y_i-\hat{Y}_i\). Residual diagnostics examine whether the model’s errors appear consistent with its assumptions. They do not prove those assumptions, and the design remains important: for example, a plot cannot establish independence if participants were measured in dependent groups or over time.
- Residuals versus fitted values: A roughly pattern-free cloud centered around zero is consistent with a suitable mean structure and constant variance. Curvature suggests that a straight-line mean may be inadequate; a funnel shape suggests changing error variance.
- Residuals versus baseline pressure: A systematic curve or changing spread can reveal a problem that is obscured in a plot against fitted values. A visible pattern calls for investigation rather than automatic acceptance of the model.
- Normal quantile plot: Points reasonably close to a straight reference line are consistent with approximately normal errors. Strong departures, especially in the tails, caution against relying uncritically on small-sample normal-theory inference.
- Unusual observations: Check large residuals and observations with unusual predictor values or substantial influence on the fitted coefficient. Verify the records and assess how sensitive the conclusion is to legitimate influential cases; do not delete a valid participant merely because the result changes.
The common-slope assumption deserves particular attention: this model represents the adjusted treatment difference as constant across baseline pressure. A residual pattern can raise concerns about model adequacy, but diagnostics alone do not provide a definitive test of that assumption. The analysis should state what was checked and how any concerning pattern affects interpretation.
Worked Example: Interpreting Residual Checks
Suppose diagnostics for the same hypothetical trial show residuals versus fitted values with no visible curve. Across three fitted-value ranges, the mean residuals are \(-0.4\), \(0.2\), and \(0.1\) mmHg, while the residual standard deviations are \(7.1\), \(7.4\), and \(7.0\) mmHg. A normal quantile plot is approximately straight, with modest tail departures. The largest studentized residual is 2.6, and one participant has a comparatively unusual combination of baseline and fitted pressure.
The residual means are all close to zero, and the residual standard deviations are similar, so these summaries do not suggest a strong mean-pattern or variance-pattern problem. The approximate straightness of the quantile plot is consistent with normal errors, although the tail departures mean normality is not exact. The residual of 2.6 and unusual predictor values merit checking the source record and the participant’s influence on the estimate. They are not, by themselves, grounds for exclusion.
Because each participant contributes one outcome and assignment was randomized individually, independence is plausible if the participants’ outcomes were not otherwise linked, such as through a shared cluster structure. These checks do not confirm independence, and they cannot prove that the linear mean model is correct. The evidence supports proceeding cautiously with the model, while reporting the diagnostics and any sensitivity to the unusual observation.
Why the Adjustment Matters—and a Common Pitfall
Baseline adjustment can use the strong relationship between pre-treatment and follow-up pressure to reduce unexplained variation and improve precision. It also provides a clear comparison at a common baseline value. In a randomized trial, baseline differences may arise by chance; adjustment addresses prognostic baseline variation rather than repairing a failure of randomization. The estimate should still be reported with its units, uncertainty, analysis sample, and diagnostic context.
A frequent mistake is to say, “The treatment lowered pressure by 5.8 mmHg in every participant.” The model estimates an average adjusted difference between randomized groups, not an individual response. Another mistake is to report only the p-value and call the treatment clinically effective. Statistical evidence and clinical importance are different questions: the interval describes uncertainty about the difference, while a clinical judgment requires relevant thresholds, benefits, risks, and context.
Check Your Understanding
Use the model and reasoning in this tutorial to answer the following questions.
- In the baseline-adjusted model, what does a treatment coefficient of \(-4.2\) mmHg mean in context?
- Why does the baseline term cancel when comparing treatment and control at the same baseline pressure?
- For a trial with 65 participants and this three-coefficient model, what are the residual degrees of freedom?
- What would a funnel-shaped residual-versus-fitted plot suggest, and why does it matter for the usual inference?
- Why is a statistically significant adjusted difference not, by itself, proof that the treatment benefit is clinically important?
- Why should baseline pressure be measured before treatment assignment when it is used as an adjustment variable?